Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05653492
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-09
First Post:
2022-12-07
Brief Title:
Safety Feasibility and Tolerability of Sulforaphane in Children with Chronic Kidney Disease
Sponsor:
University of Rochester
Organization:
University of Rochester
Study Overview
Official Title:
Safety Feasibility and Tolerability of Sulforaphane in Children with CKD
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This purpose of this study is to investigate potential new therapeutics in pediatric chronic kidney disease CKD The specific aims are to identify safe dosing and tolerability of sulforaphane SFN supplementation in children with moderate and advanced CKD Secondary objectives will include preliminary exploration of changes in oxidative and inflammatory biomarkers in response to SFN supplementation in this population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None